QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$39.53 USD
+0.44 (1.13%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $39.53 0.00 (0.00%) 6:14 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
Price, Consensus and EPS Surprise
QDEL 39.53 +0.44(1.13%)
Will QDEL be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for QDEL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QDEL
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QuidelOrtho Expands in Infectious Disease Testing With New FDA Nod
QuidelOrtho (QDEL) Up 3.8% Since Last Earnings Report: Can It Continue?
Other News for QDEL
Vanguard Group Inc's Strategic Acquisition in QuidelOrtho Corp
QuidelOrtho Corp (QDEL) Stock Price Up 3.99% on Nov 1
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Corp (QDEL) Shares Down 3.43% on Oct 21
Carlyle Group Inc. Reduces Stake in Complete Solaria Inc.